Part D Plans Want A Preferred Specialty Tier, But Not The Limit To Generics And Biosimilars
Executive Summary
Payers say Part D plans should have flexibility in determining which drugs to place on a preferred specialty tier, while manufacturers oppose the notion of a second specialty tier altogether.
You may also be interested in...
Two-Tier Specialty Drug Policy: Part D Plans Gain Formulary Flexibility But Impact May Be Limited
Use of preferred and non-preferred specialty formulary tiers will be allowed but preferred tiers are not necessarily limited to generics and biosimilars and coinsurance for non-preferred specialty drugs cannot exceed 33%.
Medicare Part D Plans May Add ‘Preferred’ Specialty Tiers To Lower Costs
But cost sharing for non-preferred specialty drugs cannot exceed the current 25%-33% coinsurance currently allowed for the specialty tier, the Centers for Medicare and Medicaid Services says in a proposed rule.
Medicare Part D Protected Classes Targeted in Last-Minute Payment Demo Update
If not reversed by the Biden Administration, demo program that puts plans at increased risk in catastrophic phase would also enhance negotiating leverage for drugs in the protected classes.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: